Position in AXGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,221,304
+$598,060 QoQ
Shares Held
36,864
+93.6% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Verition Fund Management LLC holds $72,528,337 across 25 Medical Devices names. AXGN ranks #12 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
68,000 | $22,329,160 | |
| 2 | MASI |
Masimo Corp
|
66,853 | $11,891,143 | |
| 3 | BSX |
Boston Scientific Corp
|
95,375 | $5,984,781 | |
| 4 | DXCM |
Dexcom Inc
|
75,460 | $4,738,888 | |
| 5 | IRTC |
iRhythm Holdings, Inc.
|
34,565 | $4,079,361 | |
| 6 | GMED |
Globus Medical Inc
|
45,777 | $3,944,146 | |
| 7 | ITGR |
Integer Holdings Corp
|
35,000 | $3,080,000 | |
| 8 | LIVN |
LivaNova PLC
|
40,925 | $2,601,193 |
All Filings in AXGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,221,304 | 36,864 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $623,244 | 19,042 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,132,536 | 63,483 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $572,857 | 40,860 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $209,858 | 28,986 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $151,379 | 16,019 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||